PhD project – Type 2 Diabetes and the Clinical Course of Breast Cancer is available at the Department of Clinical Epidemiology, Aarhus University, Denmark.
Deadline to Apply
May 16, 2021 (23: 59 GMT +1)
|No. of Position(s)||1|
|Research Area||– Clinical Epidemiology|
|Scholarship||“According to standard norms”|
|Workplace||Department of Clinical Epidemiology,|
|Contract Period||3 Years|
|Starting date||Sept, 2021|
- MD or similar education in health research
- A special interest and competencies in topics such as breast cancer, diabetes, chronic disease epidemiology, pharmacoepidemiology
- High level of motivation, responsibility and flexibility
- Highly enthusiastic, ambitious and team-oriented personality
- Excellent communications skills in English (written and oral)
General job description
- Manage, carry through, and conclude your research projects
- Actively participate in PhD courses
- Write scientific articles and finalize your PhD thesis
- Participate in national and international congresses
- Conduct a research stay at an institution abroad
- Teach and disseminate your research
The successful applicant will work on a 3-year research project, investigating risk factors for type II diabetes in breast cancer patients, and evaluating the influence of type II diabetes on breast cancer prognosis. The project is designed as a series of population-based cohort studies using unique Danish health registries. The successful candidate will gain valuable experience within cancer epidemiology, diabetes epidemiology, chronic diseases and pharmacoepidemiology. The successful applicant will join a closely collaborative team of PhD students/postdocs and senior researchers from the Department of Clinical Epidemiology, Department of Oncology, and STENO Diabetes Centers in Aarhus/Odense.
How to Apply?
To apply, please click APPLY ONLINE button mentioned above.
About the project/department
Breast cancer is the most common cancer in women. Due to advances in diagnosis and treatment, survival has improved. Breast cancer survivors constitute more than 20% of cancer survivors, so it is critical to identify harmful late effects of cancer treatment, such as type II diabetes. Breast cancer and type II diabetes share common risk factors and often co-exist in patients, however, the interplay between these two diseases is poorly understood. Type II diabetes may be a complication of breast cancer therapy and may exacerbate prognosis, though some type II diabetes treatments are associated with better breast cancer prognosis.
- Principal supervisor: Deirdre Cronin Fenton, PhD, Associate Professor, Department of Clinical Epidemiology, Aarhus University. Ph.: +4587168209 / E-mail: email@example.com
- Co-supervisor: Signe Borgquist, MD, PhD, Chair Professor/Consultant, Department of Oncology, Aarhus University Hospital/Aarhus University.
- For information about application requirements and mandatory attachments, please see our application guide.
- Possibility to advance professionally by developing skills and competencies within clinical epidemiology, advanced statistics, cancer epidemiology, diabetes epidemiology, teaching, and scientific publications.
- International collaboration
- Research stay abroad
- The opportunity to contribute with new knowledge within highly relevant clinical question
- A good working environment, with a mix of clinicians, postdocs, PhD students, and research year medical students and good office facilities
Deirdre Cronin Fenton
Ph.: +4587168209 / E-mail: firstname.lastname@example.org
Post expires at 8:59am on Monday May 17th, 2021 (GMT+9)